Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.

Ribaudo HJ, Daar ES, Tierney C, Morse GD, Mollan K, Sax PE, Fischl MA, Collier AC, Haas DW, DS Clinical Trials Group
J Infect Dis. 2013 207 (3): 420-5

PMID: 23148286 · PMCID: PMC3537445 · DOI:10.1093/infdis/jis690

MeSH Terms (14)

Anti-HIV Agents Antiretroviral Therapy, Highly Active Atazanavir Sulfate Bilirubin Genetic Variation Genotype Glucuronosyltransferase HIV-1 HIV Infections Humans Jaundice Oligopeptides Pyridines Ritonavir

Connections (1)

This publication is referenced by other Labnodes entities: